AU2003289652A1 - The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion - Google Patents

The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion

Info

Publication number
AU2003289652A1
AU2003289652A1 AU2003289652A AU2003289652A AU2003289652A1 AU 2003289652 A1 AU2003289652 A1 AU 2003289652A1 AU 2003289652 A AU2003289652 A AU 2003289652A AU 2003289652 A AU2003289652 A AU 2003289652A AU 2003289652 A1 AU2003289652 A1 AU 2003289652A1
Authority
AU
Australia
Prior art keywords
depresion
helicid
treat
compound
disorders caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003289652A
Inventor
Yinggu Chen
Likun Hu
Yunfeng Li
Zhipu Luo
Yanhua Wang
Zhuang Wang
Zihou Wang
Nan Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Baker Norton Pharmaceutical Co Ltd
Original Assignee
Kunming Baker Norton Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Baker Norton Pharmaceutical Co Ltd filed Critical Kunming Baker Norton Pharmaceutical Co Ltd
Publication of AU2003289652A1 publication Critical patent/AU2003289652A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
AU2003289652A 2002-12-16 2003-12-15 The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion Abandoned AU2003289652A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN02155478.1 2002-12-16
CNB021554781A CN1197581C (en) 2002-12-16 2002-12-16 Use of P-phenylaldehyde-O-beta-D-allopyranoside for treating depression
PCT/CN2003/001066 WO2004054591A1 (en) 2002-12-16 2003-12-15 The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion

Publications (1)

Publication Number Publication Date
AU2003289652A1 true AU2003289652A1 (en) 2004-07-09

Family

ID=32514449

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003289652A Abandoned AU2003289652A1 (en) 2002-12-16 2003-12-15 The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion

Country Status (3)

Country Link
CN (1) CN1197581C (en)
AU (1) AU2003289652A1 (en)
WO (1) WO2004054591A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634089A (en) * 2003-12-29 2005-07-06 昆明贝克诺顿制药有限公司 Application of P-benzaladehyde-O-beta-D-allopyranose for the treatment of neurogenic pain
CN101029065B (en) * 2007-04-11 2010-05-19 昆明贝克诺顿制药有限公司 Bean-curd pectin analogue and its use in medicine for preventing depression
CN101933933A (en) * 2010-03-16 2011-01-05 云南大学 Application of 2-fluoro-beta-D-glucoside in treating depression
CN101810632A (en) * 2010-03-16 2010-08-25 云南大学 Purpose of 4-cyan-beta-D-glucoside for curing tristimania
CN101829127B (en) * 2010-05-18 2012-02-08 云南大学 Application of 3-carbethoxyphenyl-beta-D-acetylated glucoside in treating depression
CN101829133B (en) * 2010-05-18 2012-05-23 云南大学 Application of 7-O-beta-D-acetylation sugar-coumarin in treating depression
CN102492004A (en) * 2011-11-28 2012-06-13 四川大学 Preparation method and application of 2-(4-beta-D-allose pyranoside-phenyl)-2,3-dihydroquinoline-4(1H) and 2-(4-(2,3,4,6-tetrabenzyl)-beta-D-allose pyranoside-phenyl)-2,3-benzodihydropyran
CN103059077B (en) * 2013-01-30 2015-01-21 四川大学 Helicidum derivative or salt thereof
CN105541934A (en) * 2015-12-16 2016-05-04 昆明贝克诺顿制药有限公司 Helicid analogues for treating depression

Also Published As

Publication number Publication date
CN1197581C (en) 2005-04-20
CN1507872A (en) 2004-06-30
WO2004054591A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
IL172621A0 (en) Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003216592A1 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AUPS017702A0 (en) Methods and compositions for the treatment of asthma and related disorders
AU2003256650A1 (en) Substituted thiophene carboxamide compounds for the treatment of inflammation
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2003278559A1 (en) Herbal medicine containing cyclodextrins for the treatment of ear disorders
IL163871A0 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
AU2003240545A1 (en) Use of ramoplanin to treat diseases associated with the use of antibiotics
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
GB0201025D0 (en) The treatment of degenerative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase